BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19383251)

  • 1. Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features.
    Chen ZJ; Le HB; Zhang YK; Qian LY; Li WD
    J Int Med Res; 2009; 37(2):551-6. PubMed ID: 19383251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thrombospondin in non-small cell lung cancer.
    Mascaux C; Martin B; Paesmans M; Verdebout JM; Verhest A; Vermylen P; Bosschaerts T; Ninane V; Sculier JP
    Anticancer Res; 2002; 22(2B):1273-7. PubMed ID: 12168937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer.
    Yamaguchi M; Sugio K; Ondo K; Yano T; Sugimachi K
    Lung Cancer; 2002 May; 36(2):143-50. PubMed ID: 11955648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density].
    Han ZG; Yu TT; Shan L
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer.
    Oshika Y; Masuda K; Tokunaga T; Hatanaka H; Kamiya T; Abe Y; Ozeki Y; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
    Clin Cancer Res; 1998 Jul; 4(7):1785-8. PubMed ID: 9676856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
    Volm M; Koomägi R; Mattern J
    Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of caveolin-1 expression in primary lung cancer].
    Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis.
    Ding Q; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Ma Z
    Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):395-401. PubMed ID: 29049797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.
    Bing Z; Jian-ru Y; Yao-quan J; Shi-feng C
    Cell Biochem Biophys; 2014 Sep; 70(1):327-31. PubMed ID: 24676677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
    J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
    Zhang J; Ito R; Oue N; Zhu X; Kitadai Y; Yoshida K; Nakayama H; Yasui W
    Virchows Arch; 2003 Jun; 442(6):563-8. PubMed ID: 12719977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
    Yao L; Dong H; Luo Y; Du J; Hu W
    PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
    Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
    J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].
    Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV; Shishkin MA
    Vopr Onkol; 2013; 59(6):735-9. PubMed ID: 24624783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.